It contains the active ingredient tirzepatide, which mimics the effects of two naturally occurring gut hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP)
Complete dosing chart at 5mg/ml (2ml of bacteriostatic water) At this concentration, the 7.5mg and 10mg doses require more liquid than a standard 1ml (100-unit) insulin syringe can hold

Asia-Pacific is expected to be the fastest growing region in the GLP-1 receptor agonists obesity drugs market during the forecast period due to increasing obesity rates, rising healthcare awareness, and expanding access to advanced diabetes and obesity care Long-acting GLP-1 Receptor Agonists segment dominated the GLP-1 receptor agonists obesity drugs market with a market share of 55.5% in 2024, driven by its superior weight loss efficacy, once-weekly dosing convenience, and broad adoption of drugs such as semaglutide and tirzepatide Report Scope and GLP-1 Receptor Agonists Obesity Drugs Market Segmentation GLP-1 Receptor Agonists Obesity Drugs Market Trends Expansion Beyond Diabetes Through Multi-Indication Approvals A significant and accelerating trend in the global GLP-1 receptor agonists obesity drugs market is the expansion of these therapies beyond type 2 diabetes into broader indications such as chronic obesity, cardiovascular risk reduction, and potentially even conditions such as sleep apnea and nonalcoholic steatohepatitis (NASH)

This date is determined by the compounding pharmacy based on stability data for the specific formulation and should be strictly observed
Store the liquid medication at room temperature away from light and moisture unless otherwise instructed by the product labeling or your healthcare provider
Ask yourself: Am I ready to also change how I live, not just what I weigh